JP2002517184A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002517184A5 JP2002517184A5 JP2000552151A JP2000552151A JP2002517184A5 JP 2002517184 A5 JP2002517184 A5 JP 2002517184A5 JP 2000552151 A JP2000552151 A JP 2000552151A JP 2000552151 A JP2000552151 A JP 2000552151A JP 2002517184 A5 JP2002517184 A5 JP 2002517184A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8752098P | 1998-06-01 | 1998-06-01 | |
US60/087,520 | 1998-06-01 | ||
US9118398P | 1998-06-30 | 1998-06-30 | |
US60/091,183 | 1998-06-30 | ||
PCT/US1999/012157 WO1999062941A2 (en) | 1998-06-01 | 1999-06-01 | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008278478A Division JP4871341B2 (ja) | 1998-06-01 | 2008-10-29 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
JP2011188088A Division JP5683414B2 (ja) | 1998-06-01 | 2011-08-31 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2002517184A JP2002517184A (ja) | 2002-06-18 |
JP2002517184A5 true JP2002517184A5 (ja) | 2005-11-17 |
JP4855577B2 JP4855577B2 (ja) | 2012-01-18 |
Family
ID=26777066
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000552151A Expired - Lifetime JP4855577B2 (ja) | 1998-06-01 | 1999-06-01 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
JP2008278478A Expired - Lifetime JP4871341B2 (ja) | 1998-06-01 | 2008-10-29 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
JP2011188088A Expired - Lifetime JP5683414B2 (ja) | 1998-06-01 | 2011-08-31 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
JP2014169206A Pending JP2014239695A (ja) | 1998-06-01 | 2014-08-22 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
JP2016229709A Expired - Lifetime JP6371362B2 (ja) | 1998-06-01 | 2016-11-28 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008278478A Expired - Lifetime JP4871341B2 (ja) | 1998-06-01 | 2008-10-29 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
JP2011188088A Expired - Lifetime JP5683414B2 (ja) | 1998-06-01 | 2011-08-31 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
JP2014169206A Pending JP2014239695A (ja) | 1998-06-01 | 2014-08-22 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
JP2016229709A Expired - Lifetime JP6371362B2 (ja) | 1998-06-01 | 2016-11-28 | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
Country Status (13)
Country | Link |
---|---|
US (10) | US6329503B1 (ja) |
EP (2) | EP1086223B1 (ja) |
JP (5) | JP4855577B2 (ja) |
AT (1) | ATE437947T1 (ja) |
AU (1) | AU757698C (ja) |
CA (1) | CA2328989C (ja) |
CY (1) | CY1109509T1 (ja) |
DE (1) | DE69941187D1 (ja) |
DK (1) | DK1086223T3 (ja) |
ES (2) | ES2629442T3 (ja) |
IL (2) | IL139699A0 (ja) |
PT (1) | PT1086223E (ja) |
WO (1) | WO1999062941A2 (ja) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
US20020187472A1 (en) * | 2001-03-09 | 2002-12-12 | Preeti Lal | Steap-related protein |
US6833438B1 (en) * | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
US20040048798A1 (en) * | 1999-06-01 | 2004-03-11 | Raitano Arthur B. | Nucleic acid and corresponding protein entitle 98P4B6 useful in treatment and detection of cancer |
US20060052321A1 (en) | 2002-04-05 | 2006-03-09 | Raitano Arthur B | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
US20030149531A1 (en) * | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
US20040141975A1 (en) | 1998-06-01 | 2004-07-22 | Raitano Arthur B. | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
EP1086223B1 (en) | 1998-06-01 | 2009-07-29 | Agensys, Inc. | Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
US6902892B1 (en) | 1998-10-19 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
AU5416700A (en) * | 1999-05-20 | 2000-12-12 | Fahri Saatcioglu | Differentially expressed genes in prostate cancer |
DK1244705T3 (da) * | 1999-12-06 | 2010-05-31 | Agensys Inc | Serpentintransmembrane antigener udtryk i human prostatacancere og anvendelser deraf |
AU2001236807A1 (en) * | 2000-02-10 | 2001-08-20 | Abbott Laboratories | Antibodies that bind human interleukin-18 and methods of making and using |
US7189565B2 (en) * | 2001-03-23 | 2007-03-13 | Fahri Saatcioglu | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
CA2403637A1 (en) * | 2000-03-24 | 2001-10-04 | Fahri Saatcioglu | Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
US7611892B2 (en) | 2000-03-24 | 2009-11-03 | President And Fellows Of Harvard College | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
PT1360203E (pt) | 2001-01-17 | 2009-04-03 | Intreat Pty Ltd | Anticorpos de receptor p2x7 não funcional para diagnóstico e tratamento de cancros e outros estados |
US20030194798A1 (en) | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
ES2537074T3 (es) * | 2001-09-06 | 2015-06-02 | Agensys, Inc. | Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer |
WO2003053357A2 (en) * | 2001-12-19 | 2003-07-03 | Wilk Patent Development Corporation | Method and related composition employing nanostructures |
EP2390308A1 (en) | 2002-02-25 | 2011-11-30 | Vaxiion Therapeutics Inc | Minicell compositions and methods |
WO2004016643A2 (en) * | 2002-08-16 | 2004-02-26 | Yeda Research And Development Co. Ltd. | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
JP5840351B2 (ja) * | 2002-09-06 | 2016-01-06 | アジェンシス,インコーポレイテッド | 癌の処置および検出において有用な98p4b6と称される、核酸および対応タンパク質 |
SI1725249T1 (sl) | 2003-11-06 | 2014-04-30 | Seattle Genetics, Inc. | Spojine monometilvalina, sposobne konjugacije na ligande |
NZ550816A (en) * | 2004-04-22 | 2009-12-24 | Agensys Inc | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
EP1945682A2 (en) * | 2005-10-21 | 2008-07-23 | Medivas, LLC | Poly(ester urea) polymers and methods of use |
US8940871B2 (en) | 2006-03-20 | 2015-01-27 | The Regents Of The University Of California | Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting |
WO2008043146A1 (en) * | 2006-10-10 | 2008-04-17 | Biosceptre International Limited | Antibodies against non functional p2x7 receptor |
EP2082032A4 (en) * | 2006-10-10 | 2010-06-30 | Biosceptre Int Ltd | ANTIBODIES AGAINST NON-FUNCTIONAL P2X7 RECEPTOR PRODUCING HYBRIDOMES |
EP2061814B1 (en) | 2006-10-27 | 2012-06-06 | Genentech, Inc. | Antibodies and immunoconjugates and uses therefor |
WO2009012256A1 (en) | 2007-07-16 | 2009-01-22 | Genentech, Inc. | Humanized anti-cd79b antibodies and immunoconjugates and methods of use |
DK2474557T3 (da) | 2007-07-16 | 2014-11-10 | Genentech Inc | Anti-CD79b-antistoffer og immunkonjugater og fremgangsmåder til anvendelse |
PL2187965T3 (pl) | 2007-08-17 | 2020-05-18 | Purdue Research Foundation | Koniugaty wiążący psma ligand-łącznik i sposoby ich zastosowania |
JP6126773B2 (ja) | 2007-09-04 | 2017-05-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 癌のターゲッティングおよび検出のための高親和性抗前立腺幹細胞抗原(psca)抗体 |
JP5624885B2 (ja) | 2007-09-14 | 2014-11-12 | バイオセプター・インターナショナル・リミテッド | 細胞外体液中のプリン作動性(p2x)受容体 |
CA2737126C (en) | 2007-09-14 | 2018-05-01 | Biosceptre International Limited | Novel p2x7 epitopes |
EP2740490A1 (en) * | 2007-10-03 | 2014-06-11 | Cornell University | Treatment of proliferative disorders using antibodies to PSMA |
DK2657253T3 (en) | 2008-01-31 | 2017-10-09 | Genentech Inc | Anti-CD79b antibodies and immune conjugates and methods of use |
KR101701300B1 (ko) | 2008-07-04 | 2017-02-01 | 바이오셉터 (어스트) 피티와이 엘티디 | 항p2x7 펩티드 및 에피토프 |
ES2712732T3 (es) | 2009-02-17 | 2019-05-14 | Cornell Res Foundation Inc | Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico |
WO2011020155A1 (en) | 2009-08-20 | 2011-02-24 | Biosceptre International Limited | Anti p2x7 receptor antibodies and fragments thereof |
EP2506876B1 (en) | 2009-12-02 | 2016-10-12 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
CA2784345C (en) | 2009-12-24 | 2018-11-13 | Julian Alexander Barden | Antibodies to non-functional oligomeric p2x7 receptors |
US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
MX336109B (es) | 2010-06-03 | 2016-01-08 | Genentech Inc | Formacion de imagenes inmuno-tep de anticuerpos e inmunoconjugados y usos de lo mismo. |
WO2012031333A1 (en) | 2010-09-10 | 2012-03-15 | Biosceptre International Limited | Companion animal treatments |
WO2012057765A1 (en) | 2010-10-28 | 2012-05-03 | The Board Of Regents Of The University Of Texas System | Recombinant anti-cd19 monoclonal antibodies |
JP6077450B2 (ja) * | 2010-11-12 | 2017-02-08 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | コンセンサス前立腺抗原、それをコードする核酸分子、ならびにそれを含むワクチンおよび用途 |
AU2015261742B2 (en) * | 2010-11-12 | 2017-10-26 | Inovio Pharmaceuticals, Inc. | Consensus prostate antigens nucleic acid molecule encoding the same and vaccine and uses comprising the same |
DK2675474T3 (en) | 2011-02-15 | 2019-04-23 | Vaxiion Therapeutics Llc | THERAPEUTIC COMPOSITIONS AND PROCEDURES FOR TARGETED ADMINISTRATION OF BIOACTIVE MOLECULES BY BACK-TERIAL MINICLES BASED ON ANTIBODY AND FC-CONTAINING TAR-GETING MOLECULES |
US9566318B2 (en) | 2011-07-01 | 2017-02-14 | Biosceptre (Aust) Pty Ltd | Combination therapy |
AR089028A1 (es) | 2011-11-29 | 2014-07-23 | Genentech Inc | Composiciones y metodos para el analisis de cancer de prostata |
KR102499944B1 (ko) | 2012-11-15 | 2023-02-14 | 엔도사이트, 인코포레이티드 | Psma 발현 세포에 의해 야기되는 질병을 치료하기 위한 컨쥬게이트 |
AU2014255381A1 (en) | 2013-04-17 | 2015-10-08 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
KR101782623B1 (ko) | 2013-07-10 | 2017-09-28 | 서울대학교산학협력단 | 복합 막횡단 단백질의 세포막외 펩타이드 항원 및 그의 용도 |
EP4374924A2 (en) | 2013-10-18 | 2024-05-29 | Novartis AG | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
PT3262071T (pt) | 2014-09-23 | 2020-06-16 | H Hoffnabb La Roche Ag | Métodos de utilização de imunoconjugados anti-cd79b |
US10188759B2 (en) | 2015-01-07 | 2019-01-29 | Endocyte, Inc. | Conjugates for imaging |
WO2016205176A1 (en) | 2015-06-15 | 2016-12-22 | Genentech, Inc. | Antibodies and immunoconjugates |
EP4137158A1 (en) | 2015-08-07 | 2023-02-22 | Imaginab, Inc. | Antigen binding constructs to target molecules |
EP3389693A4 (en) | 2015-12-18 | 2019-08-21 | Agilvax, Inc. | COMPOSITIONS AND METHODS RELATING TO XCT PEPTIDES |
US10772972B2 (en) * | 2016-09-23 | 2020-09-15 | Regeneron Pharmaceuticals, Inc. | Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof |
MY191926A (en) | 2016-12-01 | 2022-07-18 | Regeneron Pharma | Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging |
WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
SG11201909218RA (en) | 2017-04-03 | 2019-11-28 | Hoffmann La Roche | Antibodies binding to steap-1 |
JP2020518668A (ja) | 2017-05-01 | 2020-06-25 | アジルバックス インコーポレイテッド | xCT抗体に関連する組成物および方法 |
AU2019269685A1 (en) | 2018-05-17 | 2020-12-03 | Regeneron Pharmaceuticals, Inc. | Anti-CD63 antibodies, conjugates, and uses thereof |
BR112020026724A2 (pt) | 2018-07-02 | 2021-03-30 | Amgen Inc. | Proteína de ligação ao antígeno anti-steap1 |
AU2019307607A1 (en) * | 2018-07-18 | 2021-02-11 | Amgen Inc. | Chimeric receptors to STEAP1 and methods of use thereof |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
US5851764A (en) * | 1990-10-25 | 1998-12-22 | The Trustees Of Columbia University In The City Of New York | Human prostate tumor inducing gene-1 and uses thereof |
US5489525A (en) | 1992-10-08 | 1996-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies to prostate cells |
AU8116494A (en) | 1993-11-12 | 1995-06-13 | Kenichi Matsubara | Gene signature |
DE69735294T2 (de) * | 1996-03-25 | 2006-09-21 | Medarex Inc. | Spezifische monoklonale antikörper für die extrazelluläre domäne von protasta-spezifischem membranantigen |
US5859045A (en) | 1996-05-08 | 1999-01-12 | Novo Nordisk A/S Novo Alle | Crystalline -! 3R 4R-trans-7 methoxy 2,2-dimethyl1-3-phenyl 1-4 4-12 pyrrolidin-1 -Y1!ethoxyl 1!chromane hydrogen fumarate |
JP3955636B2 (ja) * | 1996-07-15 | 2007-08-08 | マヨ ファウンデーション フォーメディカル エデュケーション アンド リサーチ | Hk2ポリペプチドを検出するための方法 |
US5824504A (en) * | 1996-09-26 | 1998-10-20 | Elshourbagy; Nabil A. | Human 7-transmembrane receptor and DNA |
DE19641560A1 (de) * | 1996-10-09 | 1998-04-16 | Boehringer Mannheim Gmbh | Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease |
WO1998016628A1 (en) | 1996-10-15 | 1998-04-23 | The Regents Of The University Of California | Animal models of human prostate cancer progression |
WO1998018489A1 (en) | 1996-10-30 | 1998-05-07 | The Uab Research Foundation | Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies |
EP2314625B1 (en) | 1996-12-03 | 2014-05-07 | Amgen Fremont Inc. | Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
CO4870792A1 (es) | 1997-02-25 | 1999-12-27 | Corixa Corp | Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata |
HUP0002095A3 (en) | 1997-02-25 | 2002-02-28 | Corixa Corp Seattle | Compounds for immunotherapy of prostate cancer and methods for their use |
US6800746B2 (en) | 1997-02-25 | 2004-10-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
AU7592998A (en) * | 1997-05-23 | 1998-12-11 | Biogen, Inc. | Modulators of tissue regeneration |
ES2267192T3 (es) | 1997-08-01 | 2007-03-01 | Serono Genetics Institute S.A. | Ests 5' para proteinas secretadas no especificas de tejido. |
WO1999006550A2 (en) | 1997-08-01 | 1999-02-11 | Genset | 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
JPH11164691A (ja) | 1997-10-03 | 1999-06-22 | Rikagaku Kenkyusho | 胚盤胞cDNA |
US20030060612A1 (en) | 1997-10-28 | 2003-03-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
US6255049B1 (en) * | 1998-02-27 | 2001-07-03 | The Trustees Of Columbia University In The City Of New York | Detection of metastatic cancer cells using PCTA-1 |
US6048970A (en) | 1998-05-22 | 2000-04-11 | Incyte Pharmaceuticals, Inc. | Prostate growth-associated membrane proteins |
US20030064397A1 (en) | 1998-05-22 | 2003-04-03 | Incyte Genomics, Inc. | Transmembrane protein differentially expressed in prostate and lung tumors |
EP1086223B1 (en) | 1998-06-01 | 2009-07-29 | Agensys, Inc. | Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
IL140845A0 (en) | 1998-07-14 | 2002-02-10 | Corixa Corp | Compositions for therapy and diagnosis of prostate cancer |
EP1140970A4 (en) | 1998-12-17 | 2003-10-22 | Human Genome Sciences Inc | 47 HUMAN SECRETED PROTEINS |
BR0010017A (pt) | 1999-04-28 | 2002-06-11 | Univ Texas | Composições e processos para o tratamento de câncer por inibição seletiva de vegf |
CA2387696A1 (en) | 1999-06-11 | 2000-12-21 | Human Genome Sciences, Inc. | 48 human secreted proteins |
WO2001012662A2 (en) | 1999-08-17 | 2001-02-22 | Incyte Genomics, Inc. | Membrane associated proteins |
GB2354821A (en) | 1999-09-29 | 2001-04-04 | Dine O Quick | Threshold crossing counter |
AU7994200A (en) | 1999-10-04 | 2001-05-10 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
UA74798C2 (uk) | 1999-10-06 | 2006-02-15 | Байоджен Айдек Ма Інк. | Спосіб лікування раку у ссавця за допомогою поліпептиду, що протидіє взаємодії april з його рецепторами |
EP1230364A2 (en) | 1999-11-12 | 2002-08-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
DK1244705T3 (da) | 1999-12-06 | 2010-05-31 | Agensys Inc | Serpentintransmembrane antigener udtryk i human prostatacancere og anvendelser deraf |
MXPA02006934A (es) | 2000-01-14 | 2003-01-28 | Corixa Corp | Composiciones y metodos para la terapia y diagnostico de cancer de prostata. |
AU2001234944A1 (en) | 2000-02-03 | 2001-08-14 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
US20020081590A1 (en) | 2000-02-04 | 2002-06-27 | Aeomica, Inc. | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
WO2001060860A2 (en) | 2000-02-17 | 2001-08-23 | Millennium Predictive Medicine, Inc. | Genes differentially expressed in human prostate cancer and their use |
CA2403637A1 (en) | 2000-03-24 | 2001-10-04 | Fahri Saatcioglu | Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
JP2004504808A (ja) | 2000-03-27 | 2004-02-19 | コリクサ コーポレイション | 前立腺癌の治療及び診断のための組成物及び方法 |
US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
JP2004509612A (ja) | 2000-06-05 | 2004-04-02 | アバロン ファーマシューティカルズ | ガン遺伝子決定および特徴的な遺伝子群を用いた治療用スクリーニング |
US20020177552A1 (en) | 2000-06-09 | 2002-11-28 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
IL154129A0 (en) | 2000-07-28 | 2003-07-31 | Compugen Inc | Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome |
CA2420140A1 (en) | 2000-08-24 | 2002-02-28 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
EP1474528A4 (en) | 2000-10-13 | 2006-06-14 | Protein Design Labs Inc | METHODS FOR DIAGNOSING PROSTATE CANCER, COMPOSITIONS AND METHODS FOR SCREENING PROSTATE CANCER MODULATORS |
EP1341804A4 (en) | 2000-11-17 | 2005-08-24 | Nuvelo Inc | NEW NUCLEIC ACIDS AND POLYPEPTIDES |
WO2002057303A2 (en) | 2001-01-12 | 2002-07-25 | Hybrigenics | Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides |
EP1404702A4 (en) | 2001-03-21 | 2009-07-08 | Human Genome Sciences Inc | SEPARATE HUMAN PROTEINS |
WO2003009814A2 (en) | 2001-07-25 | 2003-02-06 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
ES2537074T3 (es) | 2001-09-06 | 2015-06-02 | Agensys, Inc. | Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer |
EP1308459A3 (en) | 2001-11-05 | 2003-07-09 | Research Association for Biotechnology | Full-length cDNA sequences |
US6918525B2 (en) * | 2003-05-23 | 2005-07-19 | Worktools, Inc. | Spring energized desktop stapler |
NZ550816A (en) | 2004-04-22 | 2009-12-24 | Agensys Inc | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
WO2006034488A2 (en) | 2004-09-23 | 2006-03-30 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
US7056186B1 (en) * | 2005-04-06 | 2006-06-06 | Weyenberg Karey M | Cleavage-enhancing foundation garment |
-
1999
- 1999-06-01 EP EP99955273A patent/EP1086223B1/en not_active Expired - Lifetime
- 1999-06-01 WO PCT/US1999/012157 patent/WO1999062941A2/en active Application Filing
- 1999-06-01 IL IL13969999A patent/IL139699A0/xx not_active IP Right Cessation
- 1999-06-01 JP JP2000552151A patent/JP4855577B2/ja not_active Expired - Lifetime
- 1999-06-01 ES ES09002996.8T patent/ES2629442T3/es not_active Expired - Lifetime
- 1999-06-01 CA CA2328989A patent/CA2328989C/en not_active Expired - Lifetime
- 1999-06-01 ES ES99955273T patent/ES2329851T3/es not_active Expired - Lifetime
- 1999-06-01 DK DK99955273T patent/DK1086223T3/da active
- 1999-06-01 AT AT99955273T patent/ATE437947T1/de active
- 1999-06-01 PT PT99955273T patent/PT1086223E/pt unknown
- 1999-06-01 EP EP09002996.8A patent/EP2080802B1/en not_active Expired - Lifetime
- 1999-06-01 DE DE69941187T patent/DE69941187D1/de not_active Expired - Lifetime
- 1999-06-01 AU AU43262/99A patent/AU757698C/en not_active Expired
- 1999-06-01 US US09/323,873 patent/US6329503B1/en not_active Expired - Lifetime
-
2001
- 2001-12-06 US US10/010,667 patent/US6887975B2/en not_active Expired - Lifetime
- 2001-12-06 US US10/011,095 patent/US7053186B2/en not_active Expired - Lifetime
-
2003
- 2003-12-31 US US10/750,262 patent/US7166714B2/en not_active Expired - Lifetime
-
2004
- 2004-06-01 US US10/858,887 patent/US7575749B2/en not_active Expired - Lifetime
-
2005
- 2005-09-12 US US11/225,661 patent/US7642054B2/en not_active Expired - Lifetime
-
2006
- 2006-10-12 US US11/580,538 patent/US7611904B2/en not_active Expired - Fee Related
-
2008
- 2008-10-29 JP JP2008278478A patent/JP4871341B2/ja not_active Expired - Lifetime
-
2009
- 2009-10-07 US US12/575,164 patent/US7968307B2/en not_active Expired - Fee Related
- 2009-10-07 US US12/575,092 patent/US7928201B2/en not_active Expired - Fee Related
- 2009-10-15 CY CY20091101080T patent/CY1109509T1/el unknown
-
2010
- 2010-01-26 IL IL203524A patent/IL203524A/en not_active IP Right Cessation
-
2011
- 2011-06-13 US US13/134,650 patent/US8414898B2/en not_active Expired - Fee Related
- 2011-08-31 JP JP2011188088A patent/JP5683414B2/ja not_active Expired - Lifetime
-
2014
- 2014-08-22 JP JP2014169206A patent/JP2014239695A/ja active Pending
-
2016
- 2016-11-28 JP JP2016229709A patent/JP6371362B2/ja not_active Expired - Lifetime